AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32632402 — intervention group
Group type: EXPERIMENTAL
Intervention: Slow coagulation TSCPC
Number of subjects: 78
Study 32632402 — intervention group
Group type: COMPARATOR
Intervention: Standard pop-titrated TSCPC
Number of subjects: 78
Study 35386728 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal MRI examination under the alternating direction algorithm
Number of subjects: 64
Study 35386728 — intervention group
Group type: COMPARATOR
Intervention: Conventional multimodal MRI examination
Number of subjects: 64
Study 32976224 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 compressions and 2-second pause (30c2s)
Number of subjects: 517
Study 32976224 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 compressions and 5-second pause (50c5s)
Number of subjects: 517
Study 32976224 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 compressions and 10-second pause (100c10s)
Number of subjects: 517
Study 32976224 — intervention group
Group type: COMPARATOR
Intervention: Compression-only technique
Number of subjects: 517
Study 32741251 — intervention group
Group type: EXPERIMENTAL
Intervention: Single task UE rowing
Number of subjects: 0
Study 32741251 — intervention group
Group type: EXPERIMENTAL
Intervention: Single task FB rowing
Number of subjects: 0
Study 32741251 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual task UE rowing
Number of subjects: 0
Study 32741251 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual task FB rowing
Number of subjects: 0
Study 32741251 — intervention group
Group type: COMPARATOR
Intervention: Sitting
Number of subjects: 0
Study 33098441 — intervention group
Group type: EXPERIMENTAL
Intervention: SARS-CoV-2 seroprevalence study in Geneva during the first wave of the pandemic
Number of subjects: 28340
Study 33098441 — intervention group
Group type: EXPERIMENTAL
Intervention: SARS-CoV-2 seroprevalence study in Zurich, Lausanne, Basel City/Land, Ticino, and Fribourg
Number of subjects: 28340
Study 36050204 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal Cord Stimulation (SCS) therapy (40-Hz tonic SCS)
Number of subjects: 31
Study 32406998 — intervention group
Group type: EXPERIMENTAL
Intervention: SYNERGY bioabsorbable polymer drug-eluting stent (BP-DES)
Number of subjects: 9006
Study 32406998 — intervention group
Group type: COMPARATOR
Intervention: Durable polymer drug-eluting stent (DP-DES)
Number of subjects: 9006
Study 32163564 — intervention group
Group type: EXPERIMENTAL
Intervention: OCP (ethinylestradiol 30 μg/desogestrel 150 μg or ethinylestradiol 30 μg/drospirenone 3 mg) for 12-30 days with a 5-day washout period
Number of subjects: 4116
Study 32163564 — intervention group
Group type: COMPARATOR
Intervention: No OCP
Number of subjects: 4116
Study 32163564 — intervention group
Group type: EXPERIMENTAL
Intervention: OCP
Number of subjects: 4116
Study 34156449 — intervention group
Group type: EXPERIMENTAL
Intervention: Bacterial and viral profiles generated using 16S ribosomal RNA gene sequencing and multiplex PCR.
Number of subjects: 117
Study 34156449 — intervention group
Group type: EXPERIMENTAL
Intervention: Extremely randomized trees classification models for distinguishing CAP from healthy controls.
Number of subjects: 117
Study 34156449 — intervention group
Group type: COMPARATOR
Intervention: Validation using nasopharyngeal samples from influenza patients.
Number of subjects: 117
Study 36299538 — intervention group
Group type: COMPARATOR
Intervention: Sham rTMS + C0
Number of subjects: 263
Study 36299538 — intervention group
Group type: EXPERIMENTAL
Intervention: Right rTMS + C0
Number of subjects: 263
Study 36299538 — intervention group
Group type: EXPERIMENTAL
Intervention: Left rTMS + C1
Number of subjects: 263
Study 36299538 — intervention group
Group type: EXPERIMENTAL
Intervention: Right rTMS + C1
Number of subjects: 263
Study 36299538 — intervention group
Group type: EXPERIMENTAL
Intervention: Left rTMS + C0
Number of subjects: 263
Study 34658781 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuravena® (800 mg)
Number of subjects: 20
Study 34658781 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 32917359 — intervention group
Group type: EXPERIMENTAL
Intervention: Indacaterol/glycopyrronium 110/50 μg via Breezhaler® (IND/GLY)
Number of subjects: 33
Study 32917359 — intervention group
Group type: COMPARATOR
Intervention: Salbutamol/ipratropium 2.5/0.5 mg via air driven nebulization (SAL/IPR)
Number of subjects: 33
Study 32917359 — intervention group
Group type: EXPERIMENTAL
Intervention: Indacaterol/glycopyrronium (IND/GLY)
Number of subjects: 33
Study 32917359 — intervention group
Group type: COMPARATOR
Intervention: Salbutamol/ipratropium (SAL/IPR)
Number of subjects: 33
Study 36062127 — intervention group
Group type: EXPERIMENTAL
Intervention: Juan Bi Tang (JBT) - 3 g thrice daily for 4 weeks
Number of subjects: 40
Study 36062127 — intervention group
Group type: COMPARATOR
Intervention: No treatment for 4 weeks
Number of subjects: 40
Study 33186174 — intervention group
Group type: EXPERIMENTAL
Intervention: HFFnon-CE (noncontrast single-source dual-energy computed tomography)
Number of subjects: 19
Study 33186174 — intervention group
Group type: EXPERIMENTAL
Intervention: HFFAP (contrast-enhanced single-source dual-energy computed tomography in arterial phase)
Number of subjects: 19
Study 33186174 — intervention group
Group type: EXPERIMENTAL
Intervention: HFFPVP (contrast-enhanced single-source dual-energy computed tomography in portal venous phase)
Number of subjects: 19
Study 33186174 — intervention group
Group type: EXPERIMENTAL
Intervention: HFFEP (contrast-enhanced single-source dual-energy computed tomography in equilibrium phase)
Number of subjects: 19
Study 33186174 — intervention group
Group type: EXPERIMENTAL
Intervention: Fat concentration measured on fat (water)-based images
Number of subjects: 19
Study 33175051 — intervention group
Group type: EXPERIMENTAL
Intervention: High intake of modern industrialized foods at breakfast, school break, and dinner.
Number of subjects: 58
Study 33175051 — intervention group
Group type: EXPERIMENTAL
Intervention: Food consumption frequency questionnaire applied to 58 overweight and obese students.
Number of subjects: 58
Study 33449392 — intervention group
Group type: EXPERIMENTAL
Intervention: Lovastatin 80 mg/day
Number of subjects: 77
Study 33449392 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 77
Study 32482999 — intervention group
Group type: EXPERIMENTAL
Intervention: Ephedrine
Number of subjects: 24
Study 32482999 — intervention group
Group type: COMPARATOR
Intervention: Phenylephrine
Number of subjects: 24
Study 32482999 — intervention group
Group type: EXPERIMENTAL
Intervention: Both
Number of subjects: 24
Study 35077291 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 headers
Number of subjects: 44
Study 35077291 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 headers
Number of subjects: 44
Study 35077291 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 headers
Number of subjects: 44
Study 35077291 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 44
Study 32933326 — intervention group
Group type: EXPERIMENTAL
Intervention: Esophageal cooling with the ensoETM® device
Number of subjects: 0
Study 32933326 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 36210496 — intervention group
Group type: EXPERIMENTAL
Intervention: Balance exercises with mirror therapy
Number of subjects: 38
Study 36210496 — intervention group
Group type: COMPARATOR
Intervention: Balance exercises without mirror therapy (control)
Number of subjects: 38
Study 34420061 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (4 mg/kg)
Number of subjects: 21
Study 33475737 — intervention group
Group type: EXPERIMENTAL
Intervention: HLA epitope-matched (HEM) platelets
Number of subjects: 49
Study 33475737 — intervention group
Group type: COMPARATOR
Intervention: HLA standard antigen-matched (HSM) platelets
Number of subjects: 49
Study 33475737 — intervention group
Group type: COMPARATOR
Intervention: Comparison of HEM to HSM
Number of subjects: 49
Study 33475737 — intervention group
Group type: EXPERIMENTAL
Intervention: Secondary outcomes
Number of subjects: 49
Study 33475737 — intervention group
Group type: EXPERIMENTAL
Intervention: Adequate 1-hour PCI
Number of subjects: 49
Study 33475737 — intervention group
Group type: EXPERIMENTAL
Intervention: Epitope mismatch effect on PCI
Number of subjects: 49
Study 37167798 — intervention group
Group type: EXPERIMENTAL
Intervention: NPA-O2 (nasopharyngeal apnoeic oxygenation at 18 l/min)
Number of subjects: 30
Study 37167798 — intervention group
Group type: COMPARATOR
Intervention: NoAO (preoxygenation only)
Number of subjects: 30
Study 33760230 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel percent plasma nomogram (PPN) with personalized target volume calculation
Number of subjects: 3443
Study 33760230 — intervention group
Group type: COMPARATOR
Intervention: Current simplified 1992 nomogram (control)
Number of subjects: 3443
Study 32770667 — intervention group
Group type: EXPERIMENTAL
Intervention: Generic (test) formulation of 10‐mg alfuzosin extended‐release tablets
Number of subjects: 33
Study 32770667 — intervention group
Group type: COMPARATOR
Intervention: Branded (reference) formulation of 10‐mg alfuzosin extended‐release tablets
Number of subjects: 33
Study 35263551 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical adhesive (TissuGlu) without drains
Number of subjects: 58
Study 35263551 — intervention group
Group type: COMPARATOR
Intervention: Conventional drainage placement
Number of subjects: 58
Study 33273475 — intervention group
Group type: EXPERIMENTAL
Intervention: Hepatitis B surface antigen (HBsAg) testing
Number of subjects: 1458
Study 33273475 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-hepatitis B core antibody (anti-HBc) testing
Number of subjects: 1458
Study 33273475 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibodies against hepatitis C virus (anti-HCV) testing
Number of subjects: 1458
Study 35338062 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced case management of HCV notifications (phone calls from a DoH specialist HCV nurse offering HCV management support)
Number of subjects: 170
Study 35338062 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (no enhanced case management)
Number of subjects: 170
Study 35338062 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced case management of HCV notifications
Number of subjects: 170
Study 35338062 — intervention group
Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 170
Study 32965623 — intervention group
Group type: EXPERIMENTAL
Intervention: MEL (3 mg) before exercise
Number of subjects: 13
Study 32965623 — intervention group
Group type: EXPERIMENTAL
Intervention: EX + MEL
Number of subjects: 13
Study 32965623 — intervention group
Group type: COMPARATOR
Intervention: EX + PLA
Number of subjects: 13
Study 32965623 — intervention group
Group type: EXPERIMENTAL
Intervention: Control + MEL
Number of subjects: 13
Study 32965623 — intervention group
Group type: COMPARATOR
Intervention: Control + PLA
Number of subjects: 13
Study 32560181 — intervention group
Group type: EXPERIMENTAL
Intervention: Phe-10 g
Number of subjects: 16
Study 32560181 — intervention group
Group type: EXPERIMENTAL
Intervention: Phe-5 g
Number of subjects: 16
Study 32560181 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 16
Study 36053605 — intervention group
Group type: EXPERIMENTAL
Intervention: Grunting
Number of subjects: 884
Study 36053605 — intervention group
Group type: EXPERIMENTAL
Intervention: Stridor
Number of subjects: 884
Study 36053605 — intervention group
Group type: EXPERIMENTAL
Intervention: Haemoglobin <50 g/L
Number of subjects: 884
Study 36053605 — intervention group
Group type: EXPERIMENTAL
Intervention: Malaria
Number of subjects: 884
Study 36053605 — intervention group
Group type: COMPARATOR
Intervention: Mean haemoglobin
Number of subjects: 884
Study 36053605 — intervention group
Group type: COMPARATOR
Intervention: Mean mid-upper arm circumference (MUAC)
Number of subjects: 884
Study 32717846 — intervention group
Group type: EXPERIMENTAL
Intervention: Private sector sanitation delivery (PSSD) of urine-diverting dry latrines with routine waste collection and maintenance
Number of subjects: 20
Study 32717846 — intervention group
Group type: COMPARATOR
Intervention: Government standard delivery (GSD) of cistern-flush toilets or ventilated improved pit latrines
Number of subjects: 20
Study 35272404 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiaoshen acupuncture combined with psychotherapy
Number of subjects: 78
Study 35272404 — intervention group
Group type: COMPARATOR
Intervention: Psychotherapy (Control)
Number of subjects: 78
Study 32800385 — intervention group
Group type: EXPERIMENTAL
Intervention: High-protein group (target energy 20 kcal/kg/day, protein 1.8 g/kg/day)
Number of subjects: 117
Study 32800385 — intervention group
Group type: COMPARATOR
Intervention: Medium-protein group (target energy 20 kcal/kg/day, protein 0.9 g/kg/day)
Number of subjects: 117
Study 32800385 — intervention group
Group type: EXPERIMENTAL
Intervention: High-protein group during electrical muscle stimulation period
Number of subjects: 117
Study 32800385 — intervention group
Group type: COMPARATOR
Intervention: Medium-protein group during electrical muscle stimulation period
Number of subjects: 117
Study 32800385 — intervention group
Group type: EXPERIMENTAL
Intervention: High-protein group
Number of subjects: 117
Study 34702773 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceritinib administered for 10 days prior to tumor resection
Number of subjects: 10
Study 32311983 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental group: Gastric tube pulled out 10 cm after conventional placement, no gastric juice extracted, B-ultrasonography verified placement below the esophagus or above the cardia, routine nasal feeding postoperatively.
Number of subjects: 80
Study 32311983 — intervention group
Group type: COMPARATOR
Intervention: Control group: Conventional gastric tube placement at a depth of 45 to 55 cm, gastric juice extracted, B-ultrasound positioned in the stomach instead of the cardia, postoperative nasal feeding nutrition provided.
Number of subjects: 80
Study 35177528 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical artificial disc replacement (C‐ADR)
Number of subjects: 76
Study 35177528 — intervention group
Group type: COMPARATOR
Intervention: Anterior cervical discectomy and fusion (ACDF)
Number of subjects: 76
Study 35177528 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical artificial disc replacement (C‐ADR) with segmental motion categorized into groups (0° to 3°, 4° to 6°, 7°)
Number of subjects: 76
Study 35726368 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate titrated intravenous oxytocin infusion and early amniotomy
Number of subjects: 140
Study 35726368 — intervention group
Group type: COMPARATOR
Intervention: Delayed amniotomy (after 4 h of oxytocin)
Number of subjects: 140
Study 32673497 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Number of subjects: 4616
Study 32673497 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4616
Study 35898448 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone therapy (intramuscular testosterone cypionate 200 mg every 2 weeks for 18 months)
Number of subjects: 105
Study 32965556 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcatheter aortic valve implantation (TAVI)
Number of subjects: 1118
Study 32965556 — intervention group
Group type: COMPARATOR
Intervention: Surgical aortic valve replacement (SAVR)
Number of subjects: 1118
Study 32943721 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically determined increase in adiposity (BMI)
Number of subjects: 0
Study 32943721 — intervention group
Group type: COMPARATOR
Intervention: Genetically determined increased risk of AD
Number of subjects: 0
Study 616761389 — intervention group
Group type: EXPERIMENTAL
Intervention: MobileKids Monster Manor
Number of subjects: 54
Study 616761389 — intervention group
Group type: COMPARATOR
Intervention: Daily activity feedback (steps and active minutes) via an online program
Number of subjects: 54
Study 36152109 — intervention group
Group type: COMPARATOR
Intervention: CTT (Classical Test Theory)
Number of subjects: 0
Study 36152109 — intervention group
Group type: COMPARATOR
Intervention: IRT (Item Response Theory)
Number of subjects: 0
Study 34170923 — intervention group
Group type: EXPERIMENTAL
Intervention: Fresh embryo transfer (fresh‐ET)
Number of subjects: 4510790
Study 34170923 — intervention group
Group type: EXPERIMENTAL
Intervention: Frozen embryo transfer (frozen‐ET)
Number of subjects: 4510790
Study 34170923 — intervention group
Group type: COMPARATOR
Intervention: Natural conception
Number of subjects: 4510790
Study 32853242 — intervention group
Group type: EXPERIMENTAL
Intervention: Postpartum women
Number of subjects: 784
Study 32853242 — intervention group
Group type: EXPERIMENTAL
Intervention: Neonates
Number of subjects: 784
Study 32853242 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking over 60 minutes to access healthcare
Number of subjects: 784
Study 35386589 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual simulation-based Diabetes Foot Care Education (DFCE) program
Number of subjects: 40
Study 35386589 — intervention group
Group type: COMPARATOR
Intervention: Usual diabetes care
Number of subjects: 40
Study 33298208 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% LA supplementation
Number of subjects: 6
Study 33298208 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% LA supplementation
Number of subjects: 6
Study 33298208 — intervention group
Group type: EXPERIMENTAL
Intervention: 4% LA supplementation
Number of subjects: 6
Study 33298208 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 6
Study 35615957 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness with choice
Number of subjects: 183
Study 35615957 — intervention group
Group type: EXPERIMENTAL
Intervention: Stress mindset
Number of subjects: 183
Study 35615957 — intervention group
Group type: COMPARATOR
Intervention: Mindfulness meditation
Number of subjects: 183
Study 33429135 — intervention group
Group type: EXPERIMENTAL
Intervention: Incentives for non-avoidance
Number of subjects: 160
Study 33429135 — intervention group
Group type: EXPERIMENTAL
Intervention: Instructions to refrain from avoidance
Number of subjects: 160
Study 33429135 — intervention group
Group type: EXPERIMENTAL
Intervention: Social observation of non-avoidance
Number of subjects: 160
Study 33429135 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 160
Study 32969374 — intervention group
Group type: EXPERIMENTAL
Intervention: Emergency Caesarean Section
Number of subjects: 340
Study 32969374 — intervention group
Group type: COMPARATOR
Intervention: Elective Caesarean Section
Number of subjects: 340
Study 33740332 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin-mineral complex (with different concentrations of antioxidants)
Number of subjects: 74
Study 33740332 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 74
Study 32332591 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 34
Study 32332591 — intervention group
Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 34
Study 36242924 — intervention group
Group type: EXPERIMENTAL
Intervention: Fatigue induction with modality incompatible dual-task (90-min intervention)
Number of subjects: 45
Study 36242924 — intervention group
Group type: EXPERIMENTAL
Intervention: Fatigue induction with modality compatible dual-task (90-min intervention)
Number of subjects: 45
Study 36242924 — intervention group
Group type: COMPARATOR
Intervention: Passive control group (90-min pause)
Number of subjects: 45
Study 34581617 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic gastrectomy
Number of subjects: 227
Study 34581617 — intervention group
Group type: COMPARATOR
Intervention: Open gastrectomy
Number of subjects: 227
Study 32817282 — intervention group
Group type: EXPERIMENTAL
Intervention: MBN-signature (based on MYC, BCL-2, and NFKBIA)
Number of subjects: 186
Study 32817282 — intervention group
Group type: EXPERIMENTAL
Intervention: Bortezomib in the MBN Sig-high subgroup
Number of subjects: 186
Study 32817282 — intervention group
Group type: COMPARATOR
Intervention: Standard chemoimmunotherapy
Number of subjects: 186
Study 34916072 — intervention group
Group type: COMPARATOR
Intervention: 15-minute intermittent Pringle maneuver
Number of subjects: 344
Study 34916072 — intervention group
Group type: EXPERIMENTAL
Intervention: 25-minute intermittent Pringle maneuver
Number of subjects: 344
Study 33460963 — intervention group
Group type: EXPERIMENTAL
Intervention: Sunitinib
Number of subjects: 11
Study 33460963 — intervention group
Group type: EXPERIMENTAL
Intervention: Pazopanib
Number of subjects: 11
Study 33460963 — intervention group
Group type: EXPERIMENTAL
Intervention: Tivozanib
Number of subjects: 11
Study 33460963 — intervention group
Group type: EXPERIMENTAL
Intervention: Cabozantinib
Number of subjects: 11
Study 33460963 — intervention group
Group type: EXPERIMENTAL
Intervention: Ipilimumab/Nivolumab
Number of subjects: 11
Study 33460963 — intervention group
Group type: EXPERIMENTAL
Intervention: Pembrolizumab/Axitinib
Number of subjects: 11
Study 32767163 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivolumab + Ipilimumab
Number of subjects: 0
Study 32767163 — intervention group
Group type: EXPERIMENTAL
Intervention: Axitinib
Number of subjects: 0
Study 32767163 — intervention group
Group type: EXPERIMENTAL
Intervention: Sunitinib or Pazopanib
Number of subjects: 0
Study 32767163 — intervention group
Group type: EXPERIMENTAL
Intervention: Cabozantinib
Number of subjects: 0
Study 32767163 — intervention group
Group type: EXPERIMENTAL
Intervention: Lenvatinib + Everolimus
Number of subjects: 0
Study 34839753 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational coaching
Number of subjects: 57
Study 34839753 — intervention group
Group type: COMPARATOR
Intervention: Psychoeducation
Number of subjects: 57
Study 33998553 — intervention group
Group type: EXPERIMENTAL
Intervention: prisms/constant training
Number of subjects: 60
Study 33998553 — intervention group
Group type: EXPERIMENTAL
Intervention: prisms/variable training
Number of subjects: 60
Study 33998553 — intervention group
Group type: COMPARATOR
Intervention: sham goggles/constant training
Number of subjects: 60
Study 33998553 — intervention group
Group type: COMPARATOR
Intervention: sham goggles/variable training
Number of subjects: 60
Study 34455642 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise group
Number of subjects: 82
Study 34455642 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 82
Study 33728346 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-month combined aerobic and strength exercise training program
Number of subjects: 22
Study 33728346 — intervention group
Group type: COMPARATOR
Intervention: Control group (untrained)
Number of subjects: 22
Study 34516433 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual conservative care plus a hip brace
Number of subjects: 38